← Return to Endometerial cancer with essential throbocythemia (ET) Jak 2 mutation
DiscussionEndometerial cancer with essential throbocythemia (ET) Jak 2 mutation
Gynecologic Cancers | Last Active: Oct 23, 2025 | Replies (20)Comment receiving replies
Replies to "@1995victoria I thought I would tag our original poster for a response to the question by..."
Connect

That paper Colleen cited doesn't have anything to do with ET or PV and does not at all imply that having ET would increase risk of endometrial cancer. Just because various cancers may have JAK2 mutations doesn't mean there's any causal relationship with JAK2 V617F MPNs.